Reck, M., Heymach, J., Franks, K., Gay, C. M., Ganju, V., Nordman, I., Cheng, Y., Girard, N., Åžendur, M. A. N., Celik, I., Dai, I., Koseoglu, S., Koride, S., Wang, Q., Günther, S., Hu, G., Türeci, Ã., Åžahin, U. (2025). A global phase III, double-blind, randomized trial of BNT327/PM8002 plus chemotherapy (chemo) compared to atezolizumab plus chemo in patients (pts) with first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8129